Justin Cramer

Dr. Justin Cramer

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2019 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
THTrevor J. Huff
Trevor J. Huff
PLParker E. Ludwig
Parker E. Ludwig
DSDavid Salazar
David Salazar
JCJustin Cramer
Justin Cramer

12 January 2017 in Journal of Digital Imaging
Verified
Journal Article
Closed access
PDF file
JCJustin Cramer
Justin Cramer
EQEdward Quigley
Edward Quigley
THTroy Hutchins
Troy Hutchins
LSLubdha Shah
Lubdha Shah

31 March 2016 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
JCJustin Cramer
Justin Cramer
URU.A. Rassner
U.A. Rassner
GHG.L. Hedlund
G.L. Hedlund
SUMMARY: A possible misconception among radiologists is that chronic subdural hemorrhage should show some degree of blooming on T2*–gradient recalled-echo or susceptibility-weighted sequences such as SWI and susceptibility-weighted angiography, which is not necessarily true. We present 5 cases of chronic subdural hemorrhages in infants, demonstrating intensity near or greater than that of CSF with variable amounts of hemosiderin staining along the neomembranes. We review the physiology and MR imaging physics behind the appearance of a chronic subdural hemorrhage, highlighting that the absence of a BBB can allow hemosiderin to be completely removed from the subdural compartment. Finally, we stress the importance of reviewing all multiplanar sequences for the presence of neomembranes, which can be quite subtle in the absence of hemosiderin staining and are critical for making the diagnosis of chronic subdural hemorrhage.

5 December 2024 in Bioengineering
Verified
Journal Article
Open access
PDF file
JCJustin Cramer
Justin Cramer
Ichiro IkutaIchiro Ikuta
Ichiro Ikuta
Yuxiang ZhouYuxiang Zhou
Yuxiang Zhou
The implementation of clinical 7T MRI presents both opportunities and challenges for advanced medical imaging. This tutorial provides practical considerations and experiences with 7T MRI in clinical settings. We first explore the history and evolution of MRI technology, highlighting the benefits of increased signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and susceptibility at 7T. Technical challenges such as increased susceptibility artifacts and RF inhomogeneity are also discussed, along with innovative adaptations. This review also discusses hardware and software considerations, including new parallel transmission head coils and advanced image processing techniques to optimize image quality. Safety considerations, such as managing tissue heating and susceptibility to artifacts, are also discussed. Additionally, clinical applications of 7T MRI are examined, focusing on neurological conditions such as epilepsy, multiple sclerosis, and vascular imaging. Emerging trends in the use of 7T MRI for spectroscopy, perfusion imaging, and multinuclear imaging are explored, with insights into the future of ultra-high-field MRI in clinical practice. This review aims to provide clinicians, technologists, and researchers with a roadmap for successfully implementing 7T MRI in both research and clinical environments.

1 March 2014 in RadioGraphics
Verified
Journal Article
Closed access
JCJustin Cramer
Justin Cramer
HMHoward Mann
Howard Mann
LLLester J Layfield
Lester J Layfield

19 November 2025 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
JCJustin Cramer
Justin Cramer
Ichiro IkutaIchiro Ikuta
Ichiro Ikuta
LBLeslie C. Baxter
Leslie C. Baxter
JPJonathon J. Parker
Jonathon J. Parker
YWYalin Wang
Yalin Wang
Yuxiang ZhouYuxiang Zhou
Yuxiang Zhou
BACKGROUND AND PURPOSE: Clinical adoption of 7 Tesla (7T) MRI is increasing, yet the performance of commonly used hippocampal segmentation algorithms, none of which are trained on 7T data, remains largely uncharacterized. This study evaluates segmentation accuracy at 7T using a voxel intensity–based method and examines volumetric differences between paired 3T and 7T hippocampal segmentations. MATERIALS AND METHODS: Two retrospective datasets from a single center were analyzed. For the 7T-only accuracy assessment cohort, 269 brain MRI studies performed on a Siemens Magnetom Terra.X with paired pre-and post-contrast T1 MPRAGE sequences (0.6 mm isovoxel) were utilized. For the 3T–7T cross-field comparison cohort, 39 unique subjects were identified with both 3T and 7T precontrast T1 MPRAGE sequences. Hippocampal segmentation was performed on the 7T-only cohort with AssemblyNet, e2dhipseg, FastSurfer, HippMapper, hippodeep, and QuickNat. QuickNat was removed from the 3T-7T cohort due to poor performance at 7T, and NeuroQuant 5.0 was added. Voxel intensity–based correction metrics quantified segmentation accuracy at 7T, with lower total correction volumes indicating better performance. Paired 3T–7T volume differences were assessed using the Wilcoxon signed-rank test, and corresponding NeuroQuant normative percentiles were also compared. RESULTS: At 7T, hippodeep achieved the lowest total correction volume (0.58 mL), followed by e2dhipseg (0.67 mL), FastSurfer (0.78 mL), HippMapper (0.84 mL), and AssemblyNet (0.89 mL). Welch ANOVA with Tukey post-hoc testing confirmed significant pairwise differences between all algorithms (p < 0.001). In the paired 3T–7T analysis, all algorithms yielded significantly smaller 7T volumes (p < 0.001), with mean absolute differences ranging from 0.19 mL (hippodeep) to 1.54 mL (HippMapper). NeuroQuant volumes differed by 0.54 mL, corresponding to a mean 41-point shift in normative percentiles. CONCLUSIONS: Hippodeep required the least total correction at 7T and had the smallest 3T–7T volume differences, suggesting it offers the most consistent cross-field performance among tested methods. However, consistent 7T volumetric underestimation across algorithms and the associated large normative percentile shifts from small volume changes indicate that a dedicated 7T normative database is necessary for meaningful clinical use. ABBREVIATIONS: MNI = Montreal Neurological Institute; HSD = honestly significant difference; T = Tesla.